The Cardiovascular Imaging Research Program focuses on developing and using noninvasive imaging methods that allow the early detection, prevention, and treatment of cardiovascular disease.
The goal of the cardiovascular imaging program is to develop new non-invasive imaging techniques for the diagnosis and treatment of cardiovascular disease. The primary focus of our research is atherosclerosis, a disease that is very expensive to treat. As the primary cause of heart attacks and strokes, we have worked with a variety of pharmaceutical companies to run multicenter clinical trials in our lab.
At Mount Sinai, we develop new power sequences that focus on developing new techniques for cardiovascular imaging. We are developing and applying new imaging approaches that allow the assessment not only of the structure of blood vessels, but also of the composition of the vessel walls—enabling atherosclerosis-associated abnormalities in the arteries (including the coronary arteries) to be observed down to the cellular and molecular level. We have also studied the permeability and inflammation in the arterial and vessel walls.
With state-of-the art research facilities, we are equipped with equipment including a whole body scanner to a fully integrated MRI/PET scanner, as well as a new CT scanner. This state-of-the-art equipment has allowed for higher resolution images than ever before.